Epinephrine parenteral formulations
AssigneeSomerset Therapeutics, LLC
InventorsMandar V. Shah, Santhosh Kamath, Sathiyamoorthi Natarajan, Ilango Subramanian, Veerappan Subramanian
Life of this patent
Estimating the term…
Loading patent…
AssigneeSomerset Therapeutics, LLC
InventorsMandar V. Shah, Santhosh Kamath, Sathiyamoorthi Natarajan, Ilango Subramanian, Veerappan Subramanian
Estimating the term…
The present invention relates to liquid formulations of epinephrine or a pharmaceutically acceptable salt thereof intended for parenteral administration. In particular, the invention provides liquid formulations comprising levorotatory-epinephrine (l-epinephrine) in a concentration of about 0.5 to about 1.5 mg/mL and at least one antioxidant. The antioxidant is selected from the group consisting of ascorbic acid, sodium ascorbate, monothioglycerol, vitamin-A, vitamin-B1, vitamin-B2, vitamin-B6, vitamin-E, butylated hydroxy toluene, butylated hydroxy anisole and propyl gallate, alone or in a combination. The formulations prepared by using the current invention exhibit good physical and chemical stability.
A liquid composition consisting essentially of levorotatory-epinephrine (l-epinephrine) in a concentration of about 0.5 to about 1.5 mg/mL, tartaric acid in a concentration of about 0.1 to about 4.0 mg/mL, sodium edetate in a concentration of about 0.1 to about 0.5 mg/mL, sodium chloride in a concentration of about 4.0 to about 9.0 mg/mL and water, wherein the composition is free of bisulfite as an antioxidant.
A liquid composition consisting essentially of levorotatory-epinephrine (l-epinephrine) in a concentration of about 0.5 to about 1.5 mg/mL, tartaric acid in a concentration of about 0.1 to about 4.0 mg/mL, sodium edetate in a concentration of about 0.1 to about 0.5 mg/mL, sodium chloride in a concentration of about 4.0 to about 9.0 mg/mL, optional sodium hydroxide to adjust pH, optional hydrochloric acid to adjust pH, and water, wherein the composition is free of bisulfite as an antioxidant and the composition has a pH in the range of about 2.5 to about 3.5.
A liquid injection composition of l-epinephrine in a concentration of about 1.0 mg/mL, citric acid in a concentration of about 0.1 to about 4.0 mg/mL, sodium edetate in a concentration of about 0.1 to about 0.5 mg/mL, sodium chloride in a concentration of about 4.0 to about 9.0 mg/mL water and at least one antioxidant, wherein the antioxidant is selected from the group consisting of ascorbic acid, sodium ascorbate, monothioglycerol, vitamin-A, vitamin-B1, vitamin-B2, vitamin-B6, vitamin-E, butylated hydroxy toluene, butylated hydroxy anisole and propyl gallate, alone or in a combination thereof, in a concentration of about 0.2 to about 5.0 mg/mL and the composition is free of bisulfite.
Dependencies are inferred from the claim text.